UK's Medicines and Healthcare products Regulatory Agency (MHRA) released a new report introducing "new, proportionate approaches to regulation of medicines" that aims to keep in place the same standards of safety now in place.
The report, released by MHRA 14 March, is the fifth publication in a series of reports filed under the Better Regulation of Medicines Initiative (BROMI).
The report "highlights new priority areas of work in the reclassification of medicines and in regulatory communications," including communication delivery, changes to information and reducing Anonymized Single Patient Reports (ASPRs).
Read more:
MHRA - MHRA publishes fifth report on Better Regulation of Medicines Initiative